Find Silymarin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

Australia

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Silybin a,b (mixture), 802918-57-6, Silybin (a+b), (2r,3r)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one, Legalon, Silibin
Molecular Formula
C25H22O10
Molecular Weight
482.4  g/mol
InChI Key
SEBFKMXJBCUCAI-DBMPWETRSA-N

Silymarin
A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.
1 2D Structure

Silymarin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
2.1.2 InChI
InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20?,23-,24?,25+/m0/s1
2.1.3 InChI Key
SEBFKMXJBCUCAI-DBMPWETRSA-N
2.1.4 Canonical SMILES
COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O
2.1.5 Isomeric SMILES
COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 2,3 Dehydrosilybin

2. 2,3-dehydrosilybin

3. Alepa Forte

4. Alepa-forte

5. Ardeyhepan

6. Cefasilymarin

7. Durasilymarin

8. Hepa Loges

9. Hepa Merz Sil

10. Hepa-loges

11. Hepa-merz Sil

12. Hepabesch

13. Hepar Pasc

14. Hepar-pasc

15. Heparsyx

16. Heplant

17. Lagosa

18. Legalon Forte

19. Silibin

20. Silibinin

21. Silibinin A

22. Silibinin B

23. Silybin A

24. Silybin B

25. Silybinin

26. Carsil

27. Karsil

28. Legalon

29. Silimarin

30. Silymarin

2.2.2 Depositor-Supplied Synonyms

1. Silybin A,b (mixture)

2. 802918-57-6

3. Silybin (a+b)

4. (2r,3r)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one

5. Legalon

6. Silibin

7. Silliver

8. Silybine

9. Silymarin

10. Chembl9509

11. Silibinin A-silibinin B Mixt.

12. Schembl14270800

13. Schembl22398934

14. Hy-n0779a

15. Cs-0138778

16. S0508

17. E80721

18. Silybin (mixture Of Silybin A And B) 100 Microg/ml In Acetonitrile

19. (2r,3r)-2,3-dihydro-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-1,4-benzodioxin-6-yl]-4h-1-benzopyran-4-one

20. 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine

2.3 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 482.4 g/mol
Molecular Formula C25H22O10
XLogP32.4
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count10
Rotatable Bond Count4
Exact Mass482.12129689 g/mol
Monoisotopic Mass482.12129689 g/mol
Topological Polar Surface Area155 Ų
Heavy Atom Count35
Formal Charge0
Complexity750
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)


Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


Protective Agents

Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)


4.2 ATC Code

A - Alimentary tract and metabolism

A05 - Bile and liver therapy

A05B - Liver therapy, lipotropics

A05BA - Liver therapy

A05BA03 - Silymarin


API SUPPLIERS

read-more
read-more

01

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT arrow-down
TAPI Company Banner

02

Indena

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndena - Advancing botanical science with a century of innovation, quality, and trusted global expertise.

Flag Italy
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

03

Gnosis by Lesaffre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Natural Products Expo
Not Confirmed
arrow

Gnosis by Lesaffre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Natural Products Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Natural Products Expo
Not Confirmed
arrow

05

Yangzhou Gami Biochem Co. Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Natural Products Expo
Not Confirmed
arrow

Yangzhou Gami Biochem Co. Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Natural Products Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Silymarin

About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...

Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios with over 350 products, alongside tailored CDMO services. Leveraging deep expertise and diverse technologies, we deliver flexible, high-quality solutions to meet our partners’ needs. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
TAPI Company Banner

02

Indena

Italy
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndena - Advancing botanical science with a century of innovation, quality, and trusted global expertise.

Flag Italy
Digital Content Digital Content

Silymarin

About the Company : Indena is a global leader in the identification, development, and production of high-quality plant-derived active ingredients for the pharmaceutical and health-food industries. Fou...

Indena is a global leader in the identification, development, and production of high-quality plant-derived active ingredients for the pharmaceutical and health-food industries. Founded in 1921, the company combines scientific research, GACP-compliant sourcing, and GMP-certified manufacturing across Europe and India. With a century of innovation, patented technologies, and internationally recognized quality standards, Indena delivers trusted botanical solutions worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

03

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silybin

About the Company : At Gnosis by Lesaffre, we harness the power of microorganisms to transform compounds into usable nutritional actives, probiotics, and nutritional yeasts that benefit human wellbein...

At Gnosis by Lesaffre, we harness the power of microorganisms to transform compounds into usable nutritional actives, probiotics, and nutritional yeasts that benefit human wellbeing. Our process is natural, is sustainable, and will shape the future of the industry. Our process is called biotransformation. We strive to create a world that moves better, digests better, ages better, feels better, and, ultimately, lives better thanks to microorganisms and biotransformation
blank

04

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silybin

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

05

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silybin

About the Company : Yangzhou Gami Biochem Co., Ltd. is one of the leading exporters of CDCA, UDCA from China. We mainly engaged in sales of biochemical products, API, amino acids, plant extracts, food...

Yangzhou Gami Biochem Co., Ltd. is one of the leading exporters of CDCA, UDCA from China. We mainly engaged in sales of biochemical products, API, amino acids, plant extracts, food & feed additives and other chemical materials in domestic and overseas markets.We work closely with a selected group of factories in China. All the products we supply are produced and analyzed by a highly qualified and experienced team of chemists ensuring quality products to the valued clients all over the world. The dedicated people and new innovative technologies of our contracted factories have enabled our company to supply the highest quality products to our customers worldwide.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1757269800,"product":"SILYMARIN","address":"SCO NO 96,?\\r\\n\t\t\t\t\tSECTOR 5,?\\r\\n\t\t\t\t\t\t134109","city":"N\/A","supplier":"ADV MARKETING CO","supplierCountry":"INDIA","foreign_port":"BIRGUNJ","customer":"UNITED LABORATORIES NEPAL PVT. LTD.","customerCountry":"NEPAL","quantity":"7.00","actualQuantity":"7","unit":"KGS","unitRateFc":"1800","totalValueFC":"143.2","currency":"INR","unitRateINR":1805.6728571428571,"date":"08-Sep-2025","totalValueINR":"12639.71","totalValueInUsd":"143.2","indian_port":"Raxaul","hs_no":"29331999","bill_no":"5113985","productDescription":"API","marketType":"","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"SCO NO 96,?\\r\\n\t\t\t\t\tSECTOR 5,?\\r\\n\t\t\t\t\t\t134109, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649874600,"product":"SILYMARIN E.P \/ I.P.","address":"5 C SHREE LAXMI INDUSTRAIAL ESTATE ,NEW LINK ROAD ANDHERI W","city":"MUMBAI,MAHARASHTRA","supplier":"INDENA S P A","supplierCountry":"ITALY","foreign_port":"NA","customer":"GC CHEMIE PHARMIE LTD","customerCountry":"INDIA","quantity":"300.00","actualQuantity":"300","unit":"KGS","unitRateFc":"99.8","totalValueFC":"33486.1","currency":"EURO","unitRateINR":"8421.6","date":"14-Apr-2022","totalValueINR":"2526490.85","totalValueInUsd":"33486.1","indian_port":"BOMBAY AIR","hs_no":"29329990","bill_no":"8274174","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"5 C SHREE LAXMI INDUSTRAIAL ESTATE ,NEW LINK ROAD ANDHERI W"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664130600,"product":"SILYMARIN 80% (BATCH NO. 20220417W)","address":"A-1\/2,MAHENDRU ENCLAVE G T KARNAL ROAD","city":"DELHI,DELHI","supplier":"HANGZHOU XUANDA BIOTECHNOLOGY CO LT","supplierCountry":"CHINA","foreign_port":"NA","customer":"CORAL ORGANICALS","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"33.5","totalValueFC":"16804.1","currency":"USD","unitRateINR":"2693.4","date":"26-Sep-2022","totalValueINR":"1346700","totalValueInUsd":"16804.1","indian_port":"DELHI TKD ICD","hs_no":"29321990","bill_no":"2614620","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-1\/2,MAHENDRU ENCLAVE G T KARNAL ROAD"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672252200,"product":"SILYMARIN 70% UV (NOT FOR MEDICINAL USE)","address":"NO.28, RAGHUNAYAKULU STREET,,PARKT OWN,","city":"CHENNAI,TAMIL NADU","supplier":"A WELL INGREDIENTS COLTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"DK ENTERPRISES","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"23","totalValueFC":"46674.8","currency":"USD","unitRateINR":"1923.2","date":"29-Dec-2022","totalValueINR":"3846292","totalValueInUsd":"46674.8","indian_port":"MADRAS SEA","hs_no":"29329990","bill_no":"3955481","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.28, RAGHUNAYAKULU STREET,,PARKT OWN,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701455400,"product":"SILYMARIN(NOT FOR MEDICINAL USE) CAS NO:65666-07-1","address":"NO.28, RAGHUNAYAKULU STREET,,PARKT","city":"CHENNAI,TAMIL NADU","supplier":"NINGBO HI TECH BIOCHEMICALS COLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"DK ENTERPRISES","customerCountry":"INDIA","quantity":"2500.00","actualQuantity":"2500","unit":"KGS","unitRateFc":"24.3","totalValueFC":"61482.5","currency":"USD","unitRateINR":"2047.2","date":"02-Dec-2023","totalValueINR":"5117998.12","totalValueInUsd":"61482.5","indian_port":"Madras Sea","hs_no":"29329990","bill_no":"9038205","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"ROO 602, ONE CULTURE PLAZA, NO.1349LIYUAN NORTH ROAD, NINGBOCHINA CN","customerAddress":"NO.28, RAGHUNAYAKULU STREET,,PARKT"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703097000,"product":"SILYMARINE (FOR PHARMACEUTICAL USE - ACTIVE PHARMA INGRIDENTFORM 10 NO. IL\/BD-011481 BD-113 DTD. 14.12.2021)","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"TEVA API BV","supplierCountry":"CZECH REPUBLIC","foreign_port":"PRAGUE - RUZYNE","customer":"SUN PHARMACEUTICAL INDUSTRIES LTD","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"160","totalValueFC":"16203.1","currency":"USD","unitRateINR":"13488","date":"21-Dec-2023","totalValueINR":"1348800","totalValueInUsd":"16203.1","indian_port":"Bombay Air","hs_no":"29329990","bill_no":"9347481","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"PRAGUE - RUZYNE","supplierAddress":"PIET HEIN BUILDING, PIET HEINKADE107 1019 GM AMSTERDAMTHE NETHERLANDS NL","customerAddress":"ACME PLAZA, ANDHERI KURLA ROAD,"}]
14-Apr-2022
08-Sep-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more
  • Development Update

Details:

Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.


Lead Product(s): Inulin,Choline,Silymarin

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 02, 2017

blank

01

SC Fiterman Pharma SRL

Country
arrow
BioProcess International
Not Confirmed

SC Fiterman Pharma SRL

Country
arrow
BioProcess International
Not Confirmed

Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

June 02, 2017

blank
  • Development Update

Details:

Silimarin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fatty Liver.


Lead Product(s): Silymarin,Phyllanthus Niruri,Choline

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Undisclosed

Sponsor: Fiterman Pharma SRL

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 01, 2016

blank

02

University of Medicine and Pharmacy Craiova

Country
arrow
BioProcess International
Not Confirmed

University of Medicine and Pharmacy Craiova

Country
arrow
BioProcess International
Not Confirmed

Details : Silimarin is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fatty Liver.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

February 01, 2016

blank
  • Development Update

Details:

Erlotinib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.


Lead Product(s): Erlotinib,Silymarin

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Kosin University Gospel Hospital

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 23, 2014

blank

03

MedicalLogic

Country
arrow
BioProcess International
Not Confirmed

MedicalLogic

Country
arrow
BioProcess International
Not Confirmed

Lead Product(s) : Erlotinib,Silymarin

Therapeutic Area : Oncology

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : Kosin University Gospel Hospital

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Erlotinib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 23, 2014

blank
  • Development Update

Details:

Silymarin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.


Lead Product(s): Silymarin,Inapplicable

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Rottapharm Biotech

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 10, 2013

blank

04

University of Malaya

Country
arrow
BioProcess International
Not Confirmed

University of Malaya

Country
arrow
BioProcess International
Not Confirmed

Details : Silymarin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 10, 2013

blank

Details:

Legalon (Silibinin) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hepatitis C, Chronic.


Lead Product(s): Silymarin,Interferon Alfa-2B,Ribavirin

Therapeutic Area: Infections and Infectious Diseases Brand Name: Legalon

Study Phase: Phase II/ Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 07, 2013

blank

05

BioProcess International
Not Confirmed
BioProcess International
Not Confirmed

Details : Legalon (Silibinin) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Legalon

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 07, 2013

blank

Details:

Silibinin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hepatitis C.


Lead Product(s): Silymarin,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 17, 2012

blank

06

BPI West
Not Confirmed
BPI West
Not Confirmed

Details : Silibinin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 17, 2012

blank

Details:

Legalon (Silibinin) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hepatitis C.


Lead Product(s): Silymarin,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Legalon

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Azienda Ospedaliera Universitaria Policlinico

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 26, 2012

blank

07

BioProcess International
Not Confirmed
BioProcess International
Not Confirmed

Lead Product(s) : Silymarin,Inapplicable

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : Azienda Ospedaliera Universitaria Policlinico

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Legalon (Silibinin) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hepatitis C.

Product Name : Legalon

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 26, 2012

blank
  • Development Update

Details:

Silymarin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.


Lead Product(s): Silymarin,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 13, 2010

blank

08

Bukwang Pharmaceutical

Country
arrow
BioProcess International
Not Confirmed

Bukwang Pharmaceutical

Country
arrow
BioProcess International
Not Confirmed

Details : Silymarin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 13, 2010

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Silymarin forte

Dosage Form : Capsule

Dosage Strength : 140mg

Packaging :

Approval Date : 26-03-2018

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

02

Sopharma Ad

Bulgaria
Natural Products Expo
Not Confirmed
arrow

Sopharma Ad

Bulgaria
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Carsil® Max

Dosage Form : Capsule

Dosage Strength : 110mg

Packaging :

Approval Date : 29-11-2021

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

03

Sopharma Ad

Bulgaria
Natural Products Expo
Not Confirmed
arrow

Sopharma Ad

Bulgaria
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Carsil® 22.5 mg film-coated tablets

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 22-12-2023

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

04

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Silarsil

Dosage Form : Capsule

Dosage Strength : 140mg

Packaging :

Approval Date : 26-08-2021

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Silarsil

Dosage Form : Capsule

Dosage Strength : 70mg

Packaging :

Approval Date : 26-08-2021

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

06

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Lagosa®

Dosage Form : Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

07

Natural Products Expo
Not Confirmed
arrow
arrow
Natural Products Expo
Not Confirmed

Silymarin

Brand Name : Lagosa®

Dosage Form : Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 01-11-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

08

BIOHEALTH PHARMACEUTICALS Srl

Country
Natural Products Expo
Not Confirmed
arrow

BIOHEALTH PHARMACEUTICALS Srl

Country
arrow
Natural Products Expo
Not Confirmed

Silybin

Brand Name : Silmar

Dosage Form :

Dosage Strength : 30 Cps 200 Mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

MADAUS Srl

Country
Natural Products Expo
Not Confirmed
arrow

MADAUS Srl

Country
arrow
Natural Products Expo
Not Confirmed

Silybin

Brand Name : Legalon 200

Dosage Form :

Dosage Strength : 30 Bust Grat Eff 200 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

MADAUS Srl

Country
Natural Products Expo
Not Confirmed
arrow

MADAUS Srl

Country
arrow
Natural Products Expo
Not Confirmed

Silybin

Brand Name : Legalon 70

Dosage Form :

Dosage Strength : 40 Cpr Riv 70 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 802918-57-6 / Silymarin API manufacturers, exporters & distributors?

Silymarin manufacturers, exporters & distributors 1

77

PharmaCompass offers a list of Silymarin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Silymarin manufacturer or Silymarin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Silymarin manufacturer or Silymarin supplier.

PharmaCompass also assists you with knowing the Silymarin API Price utilized in the formulation of products. Silymarin API Price is not always fixed or binding as the Silymarin Price is obtained through a variety of data sources. The Silymarin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Silymarin

Synonyms

Silybin a,b (mixture), 802918-57-6, Silybin (a+b), (2r,3r)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one, Legalon, Silibin

Cas Number

802918-57-6

About Silymarin

A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.

Karsil Manufacturers

A Karsil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Karsil, including repackagers and relabelers. The FDA regulates Karsil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Karsil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Karsil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Karsil Suppliers

A Karsil supplier is an individual or a company that provides Karsil active pharmaceutical ingredient (API) or Karsil finished formulations upon request. The Karsil suppliers may include Karsil API manufacturers, exporters, distributors and traders.

click here to find a list of Karsil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Karsil GMP

Karsil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Karsil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Karsil GMP manufacturer or Karsil GMP API supplier for your needs.

Karsil CoA

A Karsil CoA (Certificate of Analysis) is a formal document that attests to Karsil's compliance with Karsil specifications and serves as a tool for batch-level quality control.

Karsil CoA mostly includes findings from lab analyses of a specific batch. For each Karsil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Karsil may be tested according to a variety of international standards, such as European Pharmacopoeia (Karsil EP), Karsil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Karsil USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty